Regencell Bioscience Holdings Limited Ordinary Shares

RGC

...

RGC: Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Show RGC Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of RGC by members of U.S. Congress

Politician	Type	Traded
Lois Frankel House / D	Sale $1,001 - $15,000	Jan. 09, 2018
Lois Frankel House / D	Sale $1,001 - $15,000	Jan. 08, 2018
Lois Frankel House / D	Sale $1,001 - $15,000	Dec. 08, 2017
Bennet, Michael Senate / D	Sale (Full) $500,001 - $1,000,000	Dec. 08, 2017
Gary Palmer House / R	Purchase $1,001 - $15,000	Apr. 04, 2017
Bennet, Michael Senate / D	Sale (Partial) $500,001 - $1,000,000	Mar. 28, 2017

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by RGC's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on RGC's company Twitter account

WallStreetBets

Number of mentions of RGC in WallStreetBets Daily Discussion

RGC News

Recent insights relating to RGC

CNBC Recommendations

Recent picks made for RGC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RGC

Corporate Flights

Flights by private jets registered to RGC